Related Experiment Video
Updated: May 19, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
The proliferative effects of ghrelin on human gastric cancer AGS cells
1Department of Gastroenterology, Jinshan Hospital, Fudan University, Shanghai Medical College of Fudan University, Shanghai, China.
Objective:
To investigate the role of ghrelin in the gastric cancer cell line AGS and its probable mechanism.
Methods:
Cell proliferation was detected by MTT assay after treated with ghrelin or des-acyl ghrelin. The expression of growth hormone secretagogue receptor 1a (GHS-R1a) and 1b (GHS-R1b) mRNA was detected using reverse transcription polymerase chain reaction (RT-PCR). The activity of extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt was measured by Western blot in cells either treated with ghrelin or inhibitors for ERK1/2 and phosphoinositide-3 kinase (PI3K). The distribution of cell cycle phases was determined by flow cytometry analysis of DNA content.
Results:
GHS-R1a and GHS-R1b mRNA were expressed in the AGS cells. Ghrelin and des-acyl ghrelin induced AGS cell proliferation at concentrations of 1 nmol/L and 10 nmol/L but had no proliferative effect at a concentration of 100 nmol/L. The treatment of AGS cells with 10 nmol/L of ghrelin and des-acyl ghrelin resulted in the progression of the increased cells in the S phase. ERK1/2 and Akt were activated by ghrelin and des-acyl ghrelin. Specific ERK1/2 inhibitor PD98059 and PI3K inhibitor wortmannin reduced phosphorylation of ERK1/2 and Akt, respectively and blocked ghrelin- and des-acyl ghrelin-induced AGS cell proliferation.
Conclusion:
Ghrelin and des-acyl ghrelin stimulate the proliferation of gastric cancer cells via the activation of the ERK1/2 and PI3K/Akt pathway.
Insights
Ghrelin and des-acyl ghrelin stimulate gastric cancer cell proliferation by activating the ERK1/2 and PI3K/Akt pathways. These findings highlight potential therapeutic targets for gastric cancer treatment.
Area of Science:
- Gastroenterology and Oncology
- Molecular Biology
- Cell Signaling
Background:
- Ghrelin, a peptide hormone, plays a role in various physiological processes.
- Gastric cancer remains a significant global health concern with complex underlying mechanisms.
- Understanding the molecular pathways involved in gastric cancer cell growth is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effect of ghrelin and its derivative, des-acyl ghrelin, on gastric cancer cell proliferation.
- To elucidate the signaling pathways, specifically ERK1/2 and PI3K/Akt, involved in ghrelin-mediated gastric cancer cell growth.
- To identify potential molecular targets for gastric cancer treatment.
Main Methods:
- Gastric cancer cell line (AGS) proliferation was assessed using MTT assays.
- Gene expression of growth hormone secretagogue receptors (GHS-R1a and GHS-R1b) was analyzed via RT-PCR.
- Western blotting was employed to measure the activation of ERK1/2 and Akt signaling pathways.
- Flow cytometry was used to analyze cell cycle distribution.
Main Results:
- AGS cells expressed both GHS-R1a and GHS-R1b mRNA.
- Ghrelin and des-acyl ghrelin significantly increased AGS cell proliferation at specific concentrations (1 and 10 nmol/L).
- Ghrelin and des-acyl ghrelin activated the ERK1/2 and Akt signaling pathways, leading to cell cycle progression into the S phase.
Conclusions:
- Ghrelin and des-acyl ghrelin promote gastric cancer cell proliferation.
- The proliferative effect is mediated through the activation of the ERK1/2 and PI3K/Akt signaling pathways.
- These findings suggest that ghrelin signaling could be a potential therapeutic target in gastric cancer.
Related Concept Videos
Gastritis II: Pathophysiology
Mitogens and the Cell Cycle
Abnormal Proliferation
Hormones Secreted by the Stomach
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples:
GPCRs Regulate Adenylyl Cylase Activity
Two...
